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Background: Phylogenetic group D Escherichia coli clones (ST69, ST393, ST405) are increasingly reported as
multidrug resistant strains causing extra-intestinal infections. We aim to characterize inter- and intraclonal diversity
of a broad sample (isolates from different geographic locations and origins with variable antibiotic resistance
profiles, 1980-2010) and their ability to adhere and form biofilm by both a modified quantitative biofilm producing
assay and Field Emission Scanning Electron Microscopy (FESEM).
Results: High virulence scores were observed among ST69 (median 14/range 9–15) and ST393 (median 14/range
8–15) clones, particularly enriched in pap alleles, iha, kpsMTII-K5 and ompT, in contrast with ST405 (median 6/range
2–14) isolates, exhibiting frequently fyuA, malX and traT. All ST69 and ST393 and only two ST405 isolates were
classified as ExPEC. Biofilm production was detected in two non-clinical ST69 and three ST393 isolates from
different origins showing variable virulence profiles. Within each clonal group, and despite the high diversity of
PFGE-types observed, isolates from different countries and recovered over large periods of time were clustered in
a few groups sharing common virulence gene profiles among ST69 (n = 10 isolates) and ST393 (n = 9 isolates)
(fimH-iha-iutA-kpsMTII-K5-(traT)-sat-(ompT)-papA-papEF-papGII-papC) or ST405 (n = 6 isolates) (fimH-traT-fyuA-malX).
Conclusions: This study highlights the circulation of highly transmissible ST69, ST393 and ST405 variants among
different settings. Biofilm production seems not to be directly correlated with their epidemiological success.
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Multidrug resistant Escherichia coli clones of the phylo-
genetic group D causing extraintestinal human infec-
tions are increasingly reported all over the world [1-4].
Among them, E. coli clonal groups D-ST69 (also rec-
ognized as clonal group A or CGA) and D-ST393 (also
known as O15:K52:H1 clonal group) are widely spread
among different hosts, often causing urinary tract in-
fections (UTI) and conferring resistance to antibiotics
[5-10]. Isolates belonging to the D-ST405 have been
involved in the spread of genes encoding extended* Correspondence: angelasilvanovais@gmail.com
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reproduction in any medium, provided the orspectrum β-lactamases (ESBLs) (mainly CTX-M enzymes),
cephamycinases (AmpC), carbapenemases (NDM) or
methylases (AmrA, RmtB) [2,11-15]. Recent studies have
reported variants of ST69, ST393 and ST405 among
ESBL and non-ESBL-producing strains from specific lo-
cations [4,5,8,9,13,16]. The presence of genes possibly in-
volved in biofilm production detected in some of these
surveys (fimH, papC, papG, fyuA or kpsMT II) suggests
the ability of these clones to adhere and form biofilm,
which could be favouring their persistence; however, such
ability has not been specifically evaluated [5,8,13,17,18].
Biofilm growing ability of bacteria is commonly assessed
by a quantitative measure of their adherence to microti-
ter plates, although electron microscopy analyses provide
more accurate information on the biofilm structure and
presence of matrix [17-19].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.biomedcentral.com/1471-2180/13/144In this study, we aim to characterize the intraclonal di-
versity of extraintestinal pathogenic E. coli (ExPEC) iso-
lates from phylogenetic group D (ST69, ST393, ST405)
isolated from different geographic locations and sources,
and to assess their ability to adhere and form biofilm
on abiotic surfaces in order to evidence a possible con-




We analysed thirty-five E. coli isolates belonging to ST69
(n = 13), ST393 complex (10 ST393, 1 ST2321) and
ST405 complex (10 ST405, 1 ST964) isolated from mul-
tiple sources and countries. They include either isolates
associated with nosocomial or community outbreaks in dif-
ferent countries [2,4,9,12,20] or isolates collected from
non-clinical sources from distinct countries and showing
variable antibiotic resistance profiles, selected from pub-
lished papers by the end of 2010. They were recovered
from nosocomial (66%) and community-acquired infec-
tions (17%), healthy volunteers (8%), food products (6%) or
animals (3%) and produced diverse ESBL or AmpC en-
zymes. Their epidemiological features are shown in Table 1.
Isolates were taken as part of standard patient care and no
ethical approval was required for their use.
Clonal diversity
Relatedness among isolates was established by XbaI-
pulsed-field gel electrophoresis (PFGE), multi-locus se-
quence typing (MLST, http://mlst.ucc.ie/mlst/dbs/Ecoli),
and identification of E. coli phylogenetic groups and
serogroups by PCR [28]. Isolates exhibiting ≥85% hom-
ology were considered to belong to the same PFGE-type.
XbaI-profiles were compared using InfoQuest™ FP ver-
sion 5.4 software (BioRad Laboratories), by applying the
UPGMA algorithm based on the Dice coefficient (1.0%
band tolerance; 1.0% optimization).
Virulence genes profile
Screening of 38 virulence factors (VFs) including adhesins,
toxins, siderophores, polysaccharide coatings and others
(malX, usp, ibeA, iss, tsh) presumptively associated with
ExPEC isolates was performed by PCR as previously de-
scribed [8,28]. The Fisher’s exact test was used for each
comparison, a p value <0.05 being considered to reveal sig-
nificant differences. A strain satisfied the criteria for being
ExPEC if it carried two or more of the following genes:
papA, papC, sfa/focDE, afa/draBC, iutA and kpsMII [8].
Adhesion and biofilm-producing assays
The ability of D-E.coli strains to in vitro adhere was in-
vestigated by a modified quantitative biofilm production
assay, as previously described [28]. The E. coli strainCFT073 and the culture medium supplemented with 1%
(v/v) glucose were used as positive and negative controls,
respectively. Assays were performed in quintuplicate and
repeated at least 4 times. The cut-off optical density
(ODc) was defined as three standard deviations above
the mean OD of the negative control (culture medium),
and strains were classified as non-adherent (OD ≤ODc),
weakly adherent (ODc < OD ≤ 2 ×ODc), moderately ad-
herent (2 × ODc <OD ≤ 4 × ODc), or strongly adherent
(OD > 4 ×ODc). The ultrastructural analysis of biofilm
was performed by a Field Emission Scanning Electron
Microscope (FESEM) (Zeiss, Germany). Briefly, adjusted
inocula (200 μl, 0.5 McF) of each strain diluted with
1.8 ml of fresh LB supplemented with 1% (v/v) glucose
were added to 24-well plates with round glass coverslips
(1 cm diameter) put into each well and incubated at
37°C for 24 h. The content of each well was removed
and the round coverslips were washed with PBS (1%)
twice. Biofilms grown on coverslips were fixed with
2,5% glutaraldehyde in Na-cacodylate 0,1 M (pH 7.4)
buffer solution (AppliChem, Germany) for 2 h at
room temperature. Following three washing steps with the
same buffer solution, samples were dehydrated through
graded ethanol (30°, 50°, 70°, 85°, 95°, 100°) and dried with
hexamethyldisilazane (Alfa Aesar, USA) for 1 h30'. Samples
were air dried overnight and coated by sputtering with a
gold target [19].
Results and discussion
Diversity among clonal groups of E. coli phylogroup D
Isolates belonging to the three analysed STs exhibited inter
and intraclonal variability regarding the VF profile and the
ability to form biofilm. On the basis of their virulence
scores, all ST69 (n = 13/13; median = 14/range = 9-15) and
all ST393 (n = 11/11; median = 14/range = 8-15), and only
sporadic ST405 (n = 2/11; median = 6/range = 2-14) isolates
were classified as ExPEC (Table 2). While most ST69 and
ST393 carried pap alleles (papA, papC, papEF, papG II),
iha, kpsMTII-K5 and ompT, ST405 isolates frequently
contained fyuA, malX and traT, suggesting the presence
of different genomic islands among E. coli phylogroup
D isolates.
Most of the isolates exhibited a weak adherence ability to
abiotic surfaces (9 ST69, 8 ST393, 9 ST405; 0.13 <OD <
0.27) while a few strains were classified as moderately ad-
herent (3 ST393, 2 ST69 and 1 ST405; 0.29 <OD< 0.47)
or strongly adherent (2 ST69, 1 ST405; 0.49 <O.D < 0.71)
(Figure 1), and were considered as presumptive biofilm
producers. Among all the strains resulting to be moder-
ately or strongly adherent, FESEM observations revealed
the presence of aggregates and EPS matrix, both com-
patible with a biofilm development, only in two ST69
(69PT1S, 69PT2S) and three ST393 (393FR3F, 393N1H,
2321PT1H) isolates (Figure 2). These isolates corresponded
Table 1 Epidemiological data and diversity among ST69, ST393 and ST405 clonal groups






ESBL / AmpC Antibiotic resistance profileb Virulence gene profileb Reference
69 O11, O73,
O77
69_1 (I) US (4), NW (1) 1999-2002 H Urine (3), blood (2) (Cm), Sm, Su, (Te), Tp, Ts fimH,iha, iutA, kpsMTII, K5, traT, sat,
(ompT), (fyuA), papA, papEF, papGII,
papC,(papGIII), (iroN), (iss), (ireA)
[20,21]
69 O77 69_2 (I) SP (1) - H Urine - Sm, Su, Te, Tp, Ts fimH, iha, iutA, kpsMTII, K5, traT, sat,
ompT, fyuA, papA, papEF, papGII,
papC, papGIII
[20]
69 - 69_3 (I) BR (1) - H, C - - (Ak), Cm, (Gm), (Km), (Nt), Sm,
Su, (Tb), Te, Tp, Ts
fimH, iha, iutA, kpsMTII, K5, traT, sat,
ompT, fyuA, papA, papEF, papGII,
papC
[12,22]
NW (1) 2006 Urine CMY-2
69 - 69_4 (I) PT (1) 2007 H Urine - Cp, Na, Sm, Su, Tp, Ts fimH, iha, iutA, kpsMTII, K5, traT, sat,
ompT, papEF, iroN, iss
This study
69 O17 69_5 (I) US (1) - H Blood - Cm, Sm, Su, Te, Tp, Ts fimH, iha, iutA, kpsMTII, K5, traT, sat,
ompT, fyuA, papA, papEF, papGII,
papC, papGIII
[20]
69 - 69_6 (II) PT (2) 2010 S - - Km, Sm, Su, Te, Tp, Ts fimH, kpsMTII, K5, traT, ompT, papA,
papEF, papC, papGIII, bmaE, gafD,
iroN, iss
[23]
69 - 69_7 (II) NW (1) 2002 A Poultry meat - Sm, Su, Te, Ts fimH, iutA, traT, ompT, papC, iroN,
iss, tsh, ireA
[21]
393 O15 NAc US (1) 1980 H - - - fimH, iha, iutA, kpsMTII, K5, sat,
ompT, fyuA, papA, papEF, papGII,
papC, papGIII, tsh
[4]
393 O15 NAd US (1) 1998 H - - Cm, Gm, Km, Nt, Sm, Su, Tb, Te,
Tp, Ts
fimH, iha, iutA, kpsMTII, K5, sat,
ompT, fyuA, papA, papEF, papGII,
papC
[4]
393 O15 NAe US (1) 1999 H - Cp, Km, Na, Sm, Su, Te, Tp, Ts fimH, iha, iutA, kpsMTII, K5, sat, fyuA,
papA, papEF, papGII, papC, tsh,
papGI
[4]
393 O15 NAe KO (1) 2006-7 C Urine - Cp, Gm, Km, Na, Nt, Sm, Su, Tb,
Te, Tp, Ts
fimH, iha, iutA, kpsMTII, K5, K1, traT,
sat, ompT, fyuA, papA, papEF,
papGII, papC
[9]
393 O15 NAe FR (1) 2006 F Feces - Cm, Cp, Gm, Km, Na, Nt, Sm,
Su, Tb, Te, Tp, Ts
fimH, iha, iutA, kpsMTII, K5, traT, sat,
ompT, papA, papEF, papGII, papC,
iss, tsh
[24]
393 O25 NA FR (1) 2006 F Feces - Cp, Na, Sm, Su, Te, Tp, Ts fimH, iha, iutA, kpsMTII, K5, sat,
ompT, fyuA, papA, papEF, papGII,
papC, iss
[24]
393 O15 NAe FR (1) 2006 F Feces - Cm, Cp, Gm, Km, Nt, Sm, Su,
Tb, Te, Ts
fimH, iha, iutA, kpsMTII, K5, K1, traT,





















Table 1 Epidemiological data and diversity among ST69, ST393 and ST405 clonal groups (Continued)
393 O15 NA SP (1) 2002 C Urine CTX-M-14 Cp, Na, Sm, Su, Ts fimH, iha, iutA, kpsMTII, K5, sat,
papA, papEF, papGII, papC, iss, tsh
[25]
393 O15 NAe KO (1) 2006-7 C Urine - Cp, Km, Na, Sm, Su, Te, Tp, Ts fimH, iha, iutA, kpsMTII, K5, papEF,
papGII, papC
[9]
393 O15 NAe NW (1) 2005 H Urine CMY-2 Cp, Km, Na, Nf, Sm, Su, Tp, Ts fimH, iutA, kpsMTII, K5, K1, ompT,
fyuA, iss, tsh
[12]
2321 O25 NAe PT (1) 2008 H Urine TEM-like Cp, Na, Sm, Su, Te, Tp, Ts fimH, iha, iutA, kpsMTII, K5, K1, sat,
fyuA, papGII, papC, papGIII, iss, tsh,
malX, iroN
This study
405 - 405_1 (I) SP (1), KU (1)f
NW (1)




(Cp), Cm, Gm, Km, Na, (Nt), Sm,
Su, Tb, Te, Tp, Ts
FimH, (iha), iutA, (kpsMTII), traT, sat,
(malX), fyuA, (kpsMTIII), (iss), (tsh)
[2,12]
405 - 405_2 (I) NW (1) 2003 H Wound CTX-M-14 Cm, Km, Sm, Su, Te, Tp, Ts fimH, traT, malX, fyuA, kpsMTIII [12]
405 - 405_3 (I) NW (1) PT (1) f 2003-2006 H Abcess (1) Urine (1) CMY-2 (1)
CTX-M-15 (1)
(Gm), (Km), Na, Sm, Su, (Tb), Te,
Tp, Ts
fimH, (iha), iutA, (kpsMTII), traT, malX,
fyuA, (papEF), (papGIII), (iroN), (iss),
(tsh), (ireA)
[2,12]
405 - 405_4 (II) SW (1) SP (1) 2000-2005 H, C Urine (1) Blood (1) CTX-M-15
TEM-24
(Cm), Cp, (Gm), Km, Na, (Nt),
Sm, Su, Te, Tb, Tp, Ts
(fimH), (iutA), traT, malX, fyuA,
kpsMTIII, (iss), (tsh)
[2,26]
405 - 405_5 (II) SP (1) 2001 H Wound TEM-52 Cm, Cp, Gm, Km, Na, Sm, Su,
Tb, Te, Ts
traT, fyuA, kpsMTIII This study
405 - NA SP (1) 2008 C Urine CTX-M-15 Ak, Cp, Gm, Na, Tb, Ts fimH, fyuA [27]
964 - 405_7 (III) NW (1) 2003 H Respiratory CTX-M-15 Cm, CpGm, Km, Na, Nf, Sm, Su,
Tb, Te, Tp, Ts,
fimH, traT, sat, fyuA, papEF [12]
aH Hospitalized humans (obtained from representative outbreaks), C Community acquired infections (obtained from representative outbreaks), F Healthy humans (feces), A Animals, S Ready-to-eat salads. b Variability
among isolates is represented in parenthesis. cIsolates identified as biotype A, dIsolates identified as biotype B; eIsolates identified as biotype C. f Isolate considered ExPEC. ND Not determined, NA, Not applicable,
Ak Amikacin, Cm Chloramphenicol, Cp Ciprofloxacin, Gm Gentamicin, Km Kanamycin, Na Nalidixic acid, Nt Netilmicin, Nf Nitrofurantoin, Sm Streptomycin, Su Sulphonamides, Tb Tobramycin, Te Tetracyclin, Tp
Trimethoprim, Ts Trimethoprim-Sulfamethoxazole, Definitions: fimH (type 1 fimbriae), papA (P fimbriae major subunit, pyelonephritis-associated), papC (P fimbriae assembly), papEF (P fimbriae minor tip pilins), papG
allele I (papG variant), papG allele II (papG variant, pyelonephritis-associated), papG allele III (P fimbriae adhesion, cystitis-associated), sfa/focDE (S and F1C fimbriae), bmaE (Blood group M-specific adhesin), gafD
(glucosamine-specific adhesin), iha (iron-regulated-gene-homologue adhesion), sat (secreted autotransporter toxin), tsh (serine protease autotransporter), fyuA (yersiniabactin receptor) iutA (ferric aerobactin receptor),
iroN (catecholate siderophore receptor), ireA (Iron-regulated element ), kpsMTII (group II capsular polysaccharide), kpsMTII K1 (variant K1), kpsMTII K5 (variant K5), kpsMTIII (group III capsular polysaccharide), traT (serum



















Table 2 Virulence gene profiles of phylogenetic group D E. coli clonal groups
Virulence genesa
N° of isolates (%) P valuea
ST69 (n = 13) ST393 (n = 11) ST405 (n = 11) ST69 vs ST393 ST69 vs ST405 ST393 vs ST405
Adhesins
fimH 13 (100%) 11 (92%) 9 (82%) 0.480 0.199 0.590
papA 11 (85%) 8 (67%) 0 (0%) 0.378 0.000 0.001
papC 12 (92%) 10 (83%) 0 (0%) 0.593 0.000 0.000
papEF 12 (92%) 9 (75%) 2(18%) 0.322 0.001 0.012
papG allele I 0 (0%) 1 (8%) 0 (0%) 0.480 - 1.000
papG allele II 9 (69%) 10 (83%) 0 (0%) 0.645 0.001 0.000
papG allele III 9 (69%) 2 (17%) 1 (9%) 0.015 0.005 1.000
bmaE 2 (15%) 0 (0%) 0 (0%) 0.480 0.482 -
gafD 2 (15%) 0 (0%) 0 (0%) 0.480 0.482 -
iha 10 (77%) 10 (83%) 2 (18%) 1.000 0.012 0.003
Toxins
sat 10 (77%) 9 (75%) 6 (55%) 1.000 0.390 0.400
tsh 1 (8%) 7 (58%) 3 (27%) 0.011 0.300 0.214
Siderophores
fyuA 8 (62%) 8 (67%) 11 (100%) 1.000 0.041 0.093
iutA 11 (85%) 11 (92%) 6 (55%) 1.000 0.182 0.069
iroN 5 (39%) 1 (8%) 1 (9%) 0.160 0.166 1.000
ireA 2 (15%) 0 (0%) 1 (9%) 0.480 1.000 1.000
Capsule
kspMT II 12 (92%) 11 (100%) 2 (18%) 1.000 0.001 0.000
kpsMT III 0 (0%) 0 (0%) 5 (46%) - 0.011 0.014
K1 0 (0%) 4 (33%) 0 (0%) 0.039 - 0.093
K5 12 (92%) 11 (100%) 0 (0%) 1.000 0.000 0.000
Protectins
traT 13 (100%) 3 (25%) 10 (91%) 0.000 0.458 0.003
iss 5 (39%) 6 (50%) 3 (27%) 0.695 0.679 0.400
Miscellaneous
usp 1 (8%) 0 (0%) 0 (0%) 1.000 1.000 -
ompT 12 (92%) 6 (50%) 0 (0%) 0.030 0.000 0.014
malX (PAI) 0 (0%) 1 (8%) 7 (64%) 0.480 0.001 0.009
ExPEC statusb 12 (100%) 11 (100%) 2 (18%) - 0.000 0.000
Virulence score 13.23 (± 1.641) 11.67 (± 3.576) 6.27 (± 3.197) 1.000 0.007 0.053
Range 9 – 15 8 – 15 2 – 14 - - -
a p values (Fisher’s exact test) are shown in bold when p < 0.05. b ExPEC status defined by the presence of two or more among papA, papC, sfa/foc, afa/draBC, iutA
and kpsMTII, as suggested [8].
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http://www.biomedcentral.com/1471-2180/13/144to diverse clonal variants exhibiting variable virulence gene
profiles, preventing from establishing a link between this
phenotype and a given virulence gene or virulence gene
profile.
The presence of a characteristic virulence gene profile
for isolates of different E. coli clonal groups confirms re-
sults obtained in previous studies [5,8]. However, small
differences in the virulence profile observed amongclosely related isolates might be explained by the plasticity
of the genomic islands where these genes are commonly
clustered [29]. Most of the isolates were associated
with extraintestinal infections (n = 25/35; 71%), includ-
ing the non-ExPEC ST405 isolates. The lack of corres-
pondence between ExPEC status and the ability to
cause extraintestinal disease further suggests that other

























































Figure 1 Quantitative biofilm-producing assay. The vertical axis represents the median optical density (OD) of at least 15 replicas of each
isolate, determined at 570 nm. E. coli CFT073 was used as a positive control. Horizontal dotted lines represent the cut-off value between weakly
adherent (light gray) and moderately adherent (gray) (1) and strongly adherent strains (dark grey) (2).
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http://www.biomedcentral.com/1471-2180/13/144pathogenicity [30]. Our results indicate that biofilm pro-
duction seems not to be directly related with their epi-
demiological success, as already observed for the pandemic
ST131 E. coli clone [28]. Moreover, when observed in par-
ticular strains, this feature could not be linked to a specific
virulence gene or virulence profile.E. coli  393N1H (ST393) E. coli  393FR3F
E. coli  69PT1S (ST69) E. coli CFT
Figure 2 Biofilms of strongly and moderately adherent E. coli strains.
a magnification of 10.000 x using an EHT = 5.00 kV.Intraclonal diversity of ST69 isolates
Thirteen isolates corresponding to 7 PFGE types were clas-
sified in different serogroups (O11, O17, O73, O77), and
clustered in two groups on the basis of the similarity of the
XbaI restriction profiles. Cluster I comprised closely re-
lated isolates (n = 10, 73.8% homology) causing hospital or (ST393) E. coli  2321PT1H (ST393)  
073 
FESEM micrographs of biofilm-growing E. coli strains were obtained at
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http://www.biomedcentral.com/1471-2180/13/144community acquired infections that exhibited a common
virulence gene profile (80%, fimH-iha-iutA-kpsMTII-
K5-traT-sat-ompT-papA-papEF-papGII-papC). Cluster II
(n = 3, 71.8% homology) included two indistinguishable
isolates recovered from different samples of ready-to-eat
salads in Portugal and from poultry meat in Norway. They
differ in the presence of iroN, iss, bmaE (n = 2/3) and gafD
(n = 2/3), and the lack of iha, sat and papGII, observed for
isolates of cluster I. All ST69 isolates exhibited resistance
to streptomycin and trimethoprim-sulfamethoxazole, and
they were frequently resistant to tetracycline (85%), and to
chloramphenicol (46%). None of the isolates produced
ESBL, but one encoded CMY-2.
Isolates belonging to cluster I seem to have been circulat-
ing among different continents since at least 1999, as re-
flects this and other studies [31-33]. Despite of the small
sample analysed, differences among ST69 isolates from hu-
man and non-human origins suggest independent evolu-
tion of particular E. coli variants in different hosts.
Intraclonal diversity of ST393 isolates
These isolates corresponded to serogroups O15 (n = 9)
or O25 (n = 2, one of them corresponding to ST2321, a
single locus variant of ST393), and they mainly were bio-
type C (non-lactose fermenters and maltose fermenters;
n = 7, 58.3%), which seem to be more commonly ob-
served than those of biotype A (lactose and maltose fer-
menters) [4,6,34]. Most isolates analysed (n = 9/75%)
were recovered from patients and healthy individuals in
France, Spain, Korea and the USA and shared a pool of
ten virulence genes (fimH-iha-iutA-kpsMTII-K5-sat-
papA-papEF-papGII-papC) (Table 1). The ST2321 isolate
belonged to O25 serotype and shared eight out of the ten
frequent VFs, suggesting a common origin. Most isolates
were resistant to trimethoprim-sulfamethoxazole (91%),
streptomycin (91%), ciprofloxacin (82%), tetracycline
(73%) and nalidixic acid (73%). Resistance against kanamy-
cin (64%), gentamicin (36%), tobramycin (36%), netilmicin
(36%) or chloramphenicol (27%) was also observed. ESBL
or AmpC production was sporadically detected (1 CTX-
M-14, 1 TEM-like and 1 CMY-2).
The study highlights the spread of ST393 isolates of
biotype C with highly similar virulence gene profile in
different continents over almost three decades, supporting
previous observations in specific countries [5,8]. Unfortu-
nately, clonal relatedness among different strains could not
be analysed due to the spontaneous lysis of DNA, also
reported by other groups [6,34].
Intraclonal diversity of ST405 isolates
Isolates of this clonal complex (n = 11, 6 PFGE types)
were recovered from human infections (82% hospital, 18%
community), and exhibited a common virulence profile
(fimH-traT-fyuA-malX, n = 6, 55%) (Table 1). Most isolatesbelonging to cluster I (n = 6, 2 ExPEC; 77% homology)
identified in hospitalized patients from Portugal, Spain,
Norway and Kuwait contained additionally iutA and sat
(n = 5/6, 83%) whereas cluster II (n = 3 from Spain
and Switzerland; 80% homology) showed consistently
kpsMTIII but not iutA and sat. Cluster III comprised
only one isolate from Norway corresponding to a single
locus variant of ST405 (ST964). ST405 isolates were com-
monly resistant to streptomycin, sulphonamides, trimetho-
prim (91% each), kanamycin, tetracycline, nalidixic acid
(82% each), gentamicin (73%), tobramycin (64%), ciproflox-
acin (45%) and chloramphenicol (45%) (Table 1).
These results suggest that several ST405 variants seem
to be circulating in distinct countries. In contrast with
ST69 and ST393, isolates frequently produced either
ESBLs (mostly CTX-M-15, but also CTX-M-3, CTX-
M-14, TEM-24 or TEM-52) or AmpC (CMY-2) enzymes,
which might have facilitated the selection and successful
spread of diverse ST405 variants [2,13,14,35].
Conclusion
Factors responsible for the increased ability of particular
E. coli clones to successfully spread and persist are poorly
understood, and our work represents one of the few stud-
ies exploring the phenotypic traits involved in the in-
creased epidemicity of emerging antibiotic resistant E. coli
clonal groups [28,36]. The results highlight the inter and
intraclonal diversity of E. coli clones of phylogroup D and
further suggest the circulation of highly transmissible
ST69, ST393 and ST405 variants, some of them being
particularly widespread in different geographic areas and
settings. The lack of association between the ability to pro-
duce biofilm exhibited by a few strains and specific viru-
lence gene or virulence gene profiles points out the need
to further explore factors involved in the selection of par-
ticular epidemic variants with enhanced ability to colonize
and persist for extended periods of time.
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